ArticleComputational intelligence and neuroscience2022
Biomedical Diagnosis of Leukemia Using a Deep Learner Classifier.
Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Artificial intelligence for the detection of acute myeloid leukemia from microscopic blood images; a systematic review and meta-analysis.Frontiers in big data · 2024Pooled it
- Artificial inteligence and datasets for leukemia diagnosis: A scoping review of machine lerning and deep learning approaches.MethodsX · 2025Review
- Artificial Intelligence-Assisted Diagnostic Cytology and Genomic Testing for Hematologic Disorders.Cells · 2023Review
- Artificial intelligence applications in pediatric oncology diagnosis.Exploration of targeted anti-tumor therapy · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leukemia cancer is the most common type of cancer that occurs in childhood. The most common types are acute lymphocytic leukemia (ALL) and acute myelogenous leukemia (AML) which affect children and adults, respectively. Several health issues occur due to these cancers. Leukemia affects the bone marrow or the lymph nodes. Leukemia produces abnormal white blood cells via the bone marrow system. The affected white blood cells are unable to perform their tasks properly. Detecting leukemia usually requires taking a blood smear from a patient and working with expert hematologists who analyze the smear with a microscope. In this paper, a method to detect ALL and AML using a deep learner classifier is developed and proposed. The method detects both types, determines their severity, and creates a message that recommends next steps to patients. This approach works based on image segmentation and a convolutional neural network (CNN) tool called AlexNet. The obtained results from the proposed approach and using MATLAB reached more than 98% accuracy. The margin exists because several operations are needed to fully detect the blood cancer. A dataset of leukemia from the Kaggle site is used to test the developed method and illustrate its effectiveness. This dataset is C-NMC_Leukemia, and it consists of nearly 10 GB worth of 15,000 images. A confusion matrix of testing images is provided to prove the correctness of the presented approach. Furthermore, a comparative analysis between the proposed algorithm and some works from the literature is presented. This analysis compares the method used to extract features, the classifier that is utilized, the accuracy, the precision, and the recall. The obtained results indicate that the proposed method outperforms other works and produces better results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.